Abstract | BACKGROUND: METHODS: Data were obtained through questionnaires related to treatment policies regarding antiplatelet drugs from each specialized stroke management department of 765 hospitals in Japan. Data were also compared between experienced facilities (defined as facilities managing more than 10 cases per year) and those less experienced (not more than 10 cases per year) to determine experts' opinion. RESULTS: CONCLUSIONS: This survey revealed details of treatment policies, and the selection of antiplatelet drugs widely varied across facilities. Further prospective studies are necessary to improve the current unclear situation regarding the use of antiplatelet drugs for the management of moyamoya disease.
|
Authors | Koichi Oki, Masahiro Katsumata, Yoshikane Izawa, Shinichi Takahashi, Norihiro Suzuki, Kiyohiro Houkin, Research Committee on Spontaneous Occlusion of Circle of Willis (Moyamoya disease) |
Journal | Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
(J Stroke Cerebrovasc Dis)
Vol. 27
Issue 12
Pg. 3605-3612
(Dec 2018)
ISSN: 1532-8511 [Electronic] United States |
PMID | 30220629
(Publication Type: Journal Article)
|
Copyright | Copyright © 2018 National Stroke Association. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Platelet Aggregation Inhibitors
|
Topics |
- Brain Ischemia
(drug therapy, surgery)
- Disease Management
- Humans
- Japan
- Moyamoya Disease
(drug therapy, surgery)
- Platelet Aggregation Inhibitors
(therapeutic use)
|